Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYDNEY trial of sildenafil in refractory coronary artery disease
2010-023375-26Phase 2Terminated
- Sponsor
- Medical University of Vienna
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of sildenafil in coronary arteriosclerosis and angina pectoris, sponsored by Medical University of Vienna. Started May 2012; status: terminated.
02
Drugs
sildenafil
03
Conditions
coronary arteriosclerosisangina pectoris
Beyond the preview
Go deeper on 2010-023375-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023375-26.